Daiwa Securities Group’s DarioHealth DRIO Stock Holding History

Daiwa Securities Group’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-228	Closed	-$28K	–	1355
2022 Q2	$28K	Buy	+228	New	+$26.8K	﹤0.01%	1106

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Daiwa Securities Group's DRIO Position: Q3 2022 in Review

Daiwa Securities Group sold out of DarioHealth (DRIO) in Q3 2022, closing a stake of 228 shares — an estimated $28K sold.

Daiwa Securities Group first reported a position in DRIO in Q2 2022 and held it in 1 quarter. The position peaked at $28K in Q2 2022. 45 funds tracked by Wall St. Rank hold DRIO as of Q3 2022.

Daiwa Securities Group reported no remaining DarioHealth position as of Q3 2022 after selling out during the quarter.
Daiwa Securities Group sold 228 DarioHealth shares in Q3 2022, an estimated $28K.
Daiwa Securities Group first reported a position in DarioHealth in Q2 2022 and held it in 1 quarter.
Daiwa Securities Group's DarioHealth position peaked at $28K in Q2 2022.
45 funds tracked by Wall St. Rank held DarioHealth as of Q3 2022.

Based on Daiwa Securities Group's 13F filing for Q3 2022, filed 2 Nov 2022.